US Pre-Market SEC Filings Roundup — September 23, 2026

22-09-2026

Chief Accounting Officer Humes Jennifer had withheld for taxes 3,880 Common Shares at $39.77 (~$154K). Humes Jennifer holds 106,419 shares after the transaction.

• · Chief Accounting Officer Humes Jennifer had withheld for taxes 3,880 Common Shares at $39.77 (~$154K)

22-09-2026

10% owner McNealy Sean sold 35,854 Common Stock at $8.13 (~$291K). McNealy Sean holds 12,529,652 shares after the transaction. Trades executed under a Rule 10b5-1 plan.

• · 10% owner McNealy Sean sold 24,000 Common Stock at $8.79 (~$211K)
• · 10% owner McNealy Sean sold 35,854 Common Stock at $8.13 (~$291K)
• · 10% owner McNealy Sean sold 21,100 Common Stock at $8.01 (~$169K)

22-09-2026

LiveOne, Inc. filed Amendment No. 3 to its Schedule 13D, reporting an increase in its beneficial ownership of PodcastOne, Inc. to 20,804,235 shares, representing approximately 68.8% of outstanding common stock as of September 18, 2026. The filing details the exercise of 1,100,000 Bridge Warrants on May 11, 2026, and the conversion of Bridge Notes into approximately 2,341,000 shares, while also disclosing potential future strategic actions, including possible acquisitions or disposals. The Reporting Person's ownership is based on 30,252,696 shares outstanding as of August 12, 2026.

• · The Reporting Person may sell Additional Debentures of up to $11 million if certain VWAP conditions are met within 15 months of the Closing Date.
• · The Reporting Person reserves the right to engage in strategic transactions, including acquisitions, mergers, or capital raising, which could affect its ownership.
• · The Reporting Person's ownership increased from 100% pre-Spin-Out to 68.8% post-Spin-Out due to the cancellation of 127,984,230 shares and subsequent issuance of new shares.

22-09-2026

President Denier Anthony Michael sold 53,846 Class A Ordinary Shares at $8.32 (~$448K). Denier Anthony Michael holds 2,224,603 shares after the transaction. Trades executed under a Rule 10b5-1 plan.

• · President Denier Anthony Michael sold 53,846 Class A Ordinary Shares at $8.32 (~$448K)

22-09-2026

CHIEF LEGAL OFFICER POSEY BRUCE K sold 327 Common Stock at $179.95 (~$58.8K). 5 transactions reported in total. POSEY BRUCE K holds 58,688 shares after the transaction. Trades executed under a Rule 10b5-1 plan.

• · CHIEF LEGAL OFFICER POSEY BRUCE K sold 72 Common Stock at $175.54 (~$12.6K)
• · CHIEF LEGAL OFFICER POSEY BRUCE K sold 27 Common Stock at $177.98 (~$4.81K)
• · CHIEF LEGAL OFFICER POSEY BRUCE K sold 241 Common Stock at $178.96 (~$43.1K)
• · CHIEF LEGAL OFFICER POSEY BRUCE K sold 327 Common Stock at $179.95 (~$58.8K)
• · CHIEF LEGAL OFFICER POSEY BRUCE K sold 199 Common Stock at $181.03 (~$36K)

22-09-2026

Regan McMillan McGee, Chairman of MBody AI Ltd. (f/k/a Check-Cap Ltd.), filed a Schedule 13D disclosing beneficial ownership of 6,860,097 ordinary shares, representing approximately 44.9% of the outstanding shares. The stake was acquired primarily through the conversion of MBody AI Corp. shares in connection with the merger that closed on August 26, 2026, and includes 20,000 shares held by Apollo Technology Capital Corporation. The filing indicates McGee's significant control over the company, but no plans for major corporate changes beyond ongoing evaluation.

• · The merger closed on August 26, 2026, pursuant to an Agreement and Plan of Merger dated September 12, 2025.
• · McGee entered into a 180-day lock-up agreement with Northland Securities, Inc. in connection with the public offering.
• · No cash consideration was paid by McGee for the shares acquired through the merger.
• · McGee disclaims beneficial ownership of shares held by the controlled entities except to the extent of his pecuniary interest.
• · No transactions in ordinary shares were effected by McGee during the past 60 days other than the merger-related acquisition.

22-09-2026

Director CROTHALL KATHERINE D was awarded 1,047 Common Stock. 18 transactions reported in total. CROTHALL KATHERINE D holds 57,357 shares after the transaction.

• · Director CROTHALL KATHERINE D was awarded 1,047 Common Stock
• · Director CROTHALL KATHERINE D was awarded 1,037 Common Stock
• · Director CROTHALL KATHERINE D was awarded 2,765 Common Stock
• · Director CROTHALL KATHERINE D was awarded 3,000 Common Stock
• · Director CROTHALL KATHERINE D was awarded 1,734 Common Stock
• · Director CROTHALL KATHERINE D was awarded 861 Common Stock
• · Director CROTHALL KATHERINE D was awarded 1,093 Common Stock
• · Director CROTHALL KATHERINE D was awarded 1,602 Common Stock

22-09-2026

Chief Financial Officer Greenwald Taylor C had withheld for taxes 3,293 Common Shares at $40.20 (~$132K). Greenwald Taylor C holds 60,435 shares after the transaction.

• · Chief Financial Officer Greenwald Taylor C had withheld for taxes 3,293 Common Shares at $40.20 (~$132K)

22-09-2026

Director Kaplan Andrew Jay bought 52,910 Common Stock at $1.89 (~$100K). Kaplan Andrew Jay holds 104,492 shares after the transaction.

• · Director Kaplan Andrew Jay bought 52,910 Common Stock at $1.89 (~$100K)
• · Director Kaplan Andrew Jay acquired 52,910 Warrant

22-09-2026

Director Wendel Karen was awarded 32,960 Class A Common Stock. Wendel Karen holds 102,890 shares after the transaction.

• · Director Wendel Karen was awarded 32,960 Class A Common Stock
• · Director Wendel Karen was awarded 44,016 Class A Common Stock

22-09-2026

Chief Operating Officer Vichairattanawong Amaree Elizabeth exercised/converted 34,875 Common Stock. 7 transactions reported in total. Vichairattanawong Amaree Elizabeth holds 73,524 shares after the transaction.

• · Chief Operating Officer Vichairattanawong Amaree Elizabeth exercised/converted 34,875 Common Stock
• · Chief Operating Officer Vichairattanawong Amaree Elizabeth exercised/converted 19,612 Common Stock
• · Chief Operating Officer Vichairattanawong Amaree Elizabeth exercised/converted 6,537 Common Stock
• · Chief Operating Officer Vichairattanawong Amaree Elizabeth was awarded 34,875 Options to Purchase Common Stock
• · Chief Operating Officer Vichairattanawong Amaree Elizabeth was awarded 34,875 Restricted Stock Units
• · Chief Operating Officer Vichairattanawong Amaree Elizabeth exercised/converted 34,875 Restricted Stock Units
• · Chief Operating Officer Vichairattanawong Amaree Elizabeth exercised/converted 26,149 Restricted Stock Units

23-09-2026

On September 21, 2026, PJ Millennium Limited Partnership and affiliated purchasers completed the acquisition of all 650,424,192 Sale Shares in VNET Group, Inc., including 455,296,932 Seller A Shares, for an aggregate consideration of US$659,527,963. The purchasers now beneficially own 650,424,192 Class A Ordinary Shares, representing 38.1% of the outstanding Ordinary Shares, with voting rights subject to a Voting and Consortium Agreement. The transaction was funded through capital contributions and bank borrowings, and the voting term commenced on the closing date.

• · The Seller A Shares Closing occurred on September 21, 2026, completing the acquisition of all 650,424,192 Sale Shares.
• · The Voting and Consortium Agreement became effective on September 21, 2026, with the Voting Term commencing on that date.
• · The Voting Term will expire on the second anniversary of the Seller A Shares Closing, subject to extension by mutual agreement.
• · The purchasers are required to vote 50% of the Relevant Shares in accordance with written voting instructions from the Founder Parties during the Voting Term.
• · The Issuer had 1,708,970,760 Ordinary Shares issued and outstanding as of June 30, 2026, including 1,678,189,037 Class A, 30,721,723 Class B, and 60,000 Class C Ordinary Shares.
• · No Class D Ordinary Shares were issued and outstanding.
• · The Reporting Persons do not beneficially own any other Ordinary Shares or have the right to acquire any Class A Ordinary Shares beyond those disclosed.
• · No transactions in the Issuer's ordinary shares were effected by the Reporting Persons during the past 60 days, except as disclosed.
• · The funds for the acquisition were provided by PJ Millennium Limited Partnership through capital contributions and bank borrowings.

23-09-2026

Hafnia Limited (HAFN) filed a Form 6-K with the SEC on September 23, 2026, reporting the results of its Extraordinary General Meeting (EGM) held on the same date. The filing, which includes a press release as Exhibit 99.1, was signed by CFO Petrus Wouter Van Echtelt. No financial results or specific resolutions were disclosed in the filing, limiting the ability to assess performance or material impact.

• · Filing date: September 23, 2026
• · Commission File Number: 001-41996
• · Exhibit 99.1 is a press release dated September 23, 2026, titled 'Results of Extraordinary General Meeting'
• · The registrant files annual reports under Form 20-F (not Form 40-F)
• · Registered office: 10 Pasir Panjang Road, #18-01 Mapletree Business City, Singapore 117438

23-09-2026

WPP plc announced that CFO Joanne Wilson is stepping down to become CFO of Diageo plc. She will remain in her role during a transition period while a formal search for her successor is underway. The company reaffirmed its 2026 guidance is unchanged from the Interim Results released on 6 August 2026.

• · Joanne Wilson has a 12-month notice period; her exact departure date will be agreed later.
• · The Board has commenced a formal search process for a new CFO.
• · Guidance for 2026 is unchanged from that provided alongside the Interim Results on 6 August 2026.

23-09-2026

Pony AI Inc. filed its 2026 Interim Report as a Form 6-K with the SEC on September 23, 2026, covering the first half of the fiscal year. The filing, signed by CEO Dr. Jun Peng, provides unaudited interim financial results and operational updates for the autonomous driving company. No specific financial figures were disclosed in the filing itself, as it serves primarily as a cover document for the interim report exhibit.

• · Filing date: September 23, 2026
• · Commission file number: 001-42409
• · Address: 1301 Pearl Development Building 1, Mingzhu 1st Street, Hengli Town, Nansha District, Guangzhou, People's Republic of China, 511458
• · Exhibit 99.1 contains the full 2026 Interim Report

23-09-2026

Tuya Inc. filed its 2026 Interim Report (for the six months ended June 30, 2026) with the SEC on Form 6-K on September 23, 2026. The filing is a regulatory requirement due to its Hong Kong Stock Exchange listing and provides unaudited financial results for the first half of the fiscal year. The report includes key financial metrics such as revenue, gross margin, and net income, but the filing text itself does not disclose specific figures.

• · The interim report covers the first six months of the fiscal year ending December 31, 2026.
• · The filing is made pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934.
• · The report is furnished as Exhibit 99.1 to this Form 6-K.

23-09-2026

Crona Corp. (CCCP) filed its FY2025 10-K reporting no revenue for the second consecutive year, with net loss widening 41.6% YoY to $109,558 from $77,395 in 2024. Operating expenses surged 69.3% to $92,279, driven by a 3.7x increase in general and administrative expenses and a 2.3x rise in professional fees, while total assets fell 74.7% to $9,879 and the company remains in a stockholders' deficit of $217,367. The company issued 10,000,100 common shares and recorded $151,710 in debt forgiveness contributed to capital, but continues to rely on related-party advances to fund operations.

• · Revenue was $0 in both FY2025 and FY2024.
• · Interest expense decreased 24.4% YoY to $17,279 from $22,871.
• · Intangible assets were fully amortized to $0 by end of FY2025 (from $25,006).
• · Property, plant and equipment net decreased 29.8% to $9,879 due to depreciation.
• · Convertible notes payable net of discount decreased to $122,500 from $132,500.
• · Related party advances increased to $58,153 from $24,643.
• · Accounts payable decreased to $929 from $7,323.
• · Accumulated deficit widened to $417,380 from $307,822.
• · Cash balance remained $0 at year-end for both periods.
• · The company continues to rely on related-party advances to fund operations.

23-09-2026

Studio City International Holdings Ltd filed a Form 6-K with the SEC on September 23, 2026, covering the month of September 2026. The filing includes an announcement as Exhibit 99.1, but the content of the announcement is not provided in the filing text. No financial figures or operational metrics are disclosed in the available content.

23-09-2026

ICICI Bank Limited announced that its Board of Directors will meet on October 17, 2026 to consider and approve the unaudited financial results for the quarter and six months ending September 30, 2026. In connection with this, the trading window for designated persons and their immediate relatives will be closed from October 1, 2026 to October 19, 2026. The filing is a routine disclosure and contains no financial performance data or period-over-period comparisons.

• · Board meeting scheduled for October 17, 2026.
• · Trading window closure from October 1, 2026 to October 19, 2026 for designated persons and their immediate relatives.
• · Results to cover quarter and six months ending September 30, 2026.

23-09-2026

Ionis Pharmaceuticals and partner Roche reported positive prespecified interim results from the Phase 3 IMAgINATION study of sefaxersen in IgA nephropathy (IgAN). The study met its primary endpoint with statistically significant and clinically meaningful reductions in proteinuria at 37 weeks, and the safety profile was consistent with prior data. The study will continue blinded to evaluate kidney function over two years, and interim data will be presented at an upcoming medical congress and shared with health authorities.

• · Sefaxersen is a once-monthly subcutaneous injection designed for self-administration.
• · IgAN affects at least 25 adults per million worldwide each year and is typically diagnosed before age 40.
• · Up to 50% of IgAN patients progress to end-stage kidney disease within 20 years of diagnosis.
• · Roche licensed sefaxersen from Ionis for complement-mediated diseases; Ionis received upfront payment, license fee, and development milestone payments and is eligible for regulatory/sales milestones and tiered royalties.
• · The study enrolled 459 patients randomized 1:1 to sefaxersen or placebo for 105 weeks.

23-09-2026

Alterity Therapeutics Ltd filed a Form 6-K with the SEC on September 23, 2026, attaching its September 2026 corporate presentation. As a development-stage enterprise, the filing provides an update on the company's pipeline and strategy but does not disclose any financial results or material operational milestones.

• · The filing incorporates by reference the company's Registration Statements on Form S-8 (File Nos. 333-251073, 333-248980, 333-228671) and Form F-3 (File No. 333-274816).
• · The company is a development-stage enterprise.

23-09-2026

Royal Caribbean Cruises Ltd. announced on September 23, 2026, that it has entered into definitive agreements to acquire a 50% equity interest in the business comprising Sandals and Beaches Resorts for a base purchase price of approximately $3.0 billion in cash. The company has secured committed debt financing from Morgan Stanley to fund the investment, and the transaction is expected to close in early 2027, subject to customary approvals and closing conditions. This strategic move expands Royal Caribbean's presence in the resort market, but the significant cash outlay and reliance on debt financing introduce execution and integration risks.

• · Transaction expected to close in early 2027, subject to customary approvals and closing conditions.
• · Debt financing committed by Morgan Stanley.
• · Press release furnished as Exhibit 99.1.

23-09-2026

Boston Scientific announced that Executive Vice President and Group President, MedSurg and Asia Pacific, Arthur C. Butcher, will retire effective January 1, 2027, and remain as a senior advisor through February 26, 2027. He will receive a prorated base salary of $780,000 during the advisory period. The company expects to enter into a retirement agreement with materially consistent benefits under existing plans.

• · Retirement effective date: January 1, 2027
• · Senior advisor period ends February 26, 2027 (Retirement Date)
• · Retirement Agreement benefits are materially consistent with Executive Retirement Plan, 2026 Annual Bonus Plan, and Long-Term Incentive Program

23-09-2026

Everest Consolidator Acquisition Corp is seeking stockholder approval to extend its business combination deadline from December 31, 2026 to December 31, 2027, via an Extension Amendment to the charter and a Trust Amendment to the Investment Management Trust Agreement. As of the record date, the trust account held $6,787,112.69 (including interest, net of taxes used), but the company cannot predict the amount remaining after redemptions and may need to seek additional funds. If the extension is not approved, the company will redeem all outstanding public shares and dissolve, with warrants expiring worthless.

• · Company incorporated on March 8, 2021.
• · IPO consummated on November 29, 2021.
• · Initial stockholders have waived redemption rights for founder shares and public shares in connection with charter amendment vote.
• · If extension is approved, public stockholders may elect to redeem shares now; those not redeeming retain future voting and redemption rights.
• · Trust funds are invested in U.S. government securities or money market funds meeting Rule 2a-7 conditions; company may direct liquidation to cash to mitigate investment company risk.

23-09-2026

AITX filed a Form 8-K on September 23, 2026, announcing a press release titled 'AITX's RAD Expands National Dealer Relationship with Third Order.' The filing is furnished under Item 8.01 and includes the press release as Exhibit 99.1, but provides no financial details or operational metrics. The announcement indicates continued business momentum for the company's RAD subsidiary, though no specific figures were disclosed.

• · The press release is titled 'AITX's RAD Expands National Dealer Relationship with Third Order'.
• · The filing is dated September 23, 2026, and was signed by CEO Steven Reinharz.
• · The company's principal executive offices are located at 10800 Galaxie Avenue, Ferndale, Michigan.

23-09-2026

AstraZeneca announced that the European Commission has approved Trixeo Aerosphere (budesonide/glycopyrronium/formoterol fumarate dihydrate) for the maintenance treatment of asthma in patients aged 12 years and older who are inadequately controlled on a medium-dose inhaled corticosteroid (ICS) and long-acting beta2-agonist (LABA). The approval is based on positive Phase III KALOS and LOGOS trial results showing statistically significant improvements in lung function and a reduction in severe asthma exacerbations versus dual ICS/LABA comparators, including in patients with no prior exacerbations. Trixeo is the first triple-combination therapy approved in the EU for this broad asthma population, expanding its use beyond COPD.

• · Trixeo demonstrated rapid onset of action with significant improvement in lung function within five minutes after the first dose (key secondary endpoint).
• · Results from KALOS and LOGOS were published in The Lancet Respiratory Medicine in February 2026.
• · No new safety or tolerability signals were identified in the trials.
• · Trixeo/Breztri is already approved for asthma in the US and Japan, and is under review in China and other countries.
• · Breztri/Trixeo is approved for COPD in more than 90 countries worldwide.

23-09-2026

Tower Semiconductor announced its 2026 Technical Global Symposium (TGS) to be held on November 17, 2026, in Santa Clara, California, USA. The event will feature a CEO keynote, an executive panel with leaders from Google AI, Arista, Coherent, and Terahop, and technical sessions showcasing advanced process technologies. This marks the company's second TGS of the year, following a successful event in Shenzhen, China, underscoring its commitment to global customer engagement and technology leadership.

• · The symposium will be held on November 17, 2026, in Santa Clara, California, USA.
• · The event follows a highly successful 2026 TGS in Shenzhen, China, earlier in the year.
• · Featured panelists include Oliver Sun (CTO, Terahop), Hong Liu (VP & Fellow, Google AI22), Julie Sheridan Eng (CTO, Coherent), and Andy Bechtolsheim (Founder and Chief Architect, Arista).
• · Tower Semiconductor owns one 200mm facility in Israel, two 200mm facilities in the U.S., and two facilities in Japan (200mm and 300mm) through its 51% holdings in TPSCo, and shares a 300mm facility in Agrate, Italy with STMicroelectronics.

23-09-2026

Caledonia Mining Corporation Plc filed a Form 6-K with the SEC on September 23, 2026, attaching a press release of the same date. The filing is a routine foreign issuer report and does not contain any financial results, operational updates, or material events beyond the existence of the press release.

• · Filing type: Form 6-K (Report of Foreign Private Issuer)
• · Filing date: September 23, 2026
• · Commission file number: 001-38164
• · Principal executive office: 2 Mulcaster Street, St Helier, Jersey JE2 3NJ
• · Exhibit 99.1 is a press release dated September 23, 2026

23-09-2026

Ispire Technology Inc. published an updated investor presentation on September 22, 2026, highlighting Q4 FY2026 revenue growth of 33% YoY to $26.7M and a 28.6% reduction in operating expenses. The company reported $96M in trailing twelve-month revenue as of June 30, 2026, and emphasized its exclusive nicotine manufacturing license in Malaysia, expansion into the nicotine pouch market, and FDA regulatory progress. However, the filing is a routine Regulation FD disclosure and does not contain any negative or flat metrics beyond the general forward-looking risk factors.

• · Global e-cigarette market estimated at $73B with 13% CAGR.
• · Illicit e-cigarette market estimated at $50B.
• · FDA provided a pathway to flavors in April 2026 guidance.
• · Ispire is the only company with an e-cigarette manufacturing license in Malaysia and holds one of two nicotine pouch manufacturing licenses there.
• · New 136,000 sq ft facility will bring total capacity to 61M devices or 107M pods per month across up to 70 production lines.
• · E-cigarettes represent 84% of TTM revenue.
• · Company holds ISO 9001:2015, ISO 14001:2015, and ISO 13485:2016 certifications.

23-09-2026

Apimeds Pharmaceuticals US, Inc. (APUS) filed an 8-K on September 23, 2026, reporting a 1-for-10 reverse stock split that became effective July 24, 2026. The split reduced outstanding shares from 15,091,180 to 1,509,118, with an additional 33,506 shares issued to round up fractional shares. The par value was also reduced from $0.01 to $0.001 per share, while the number of authorized shares remained unchanged.

• · The reverse stock split was approved by stockholders holding a majority of voting power via written consent on December 1, 2025.
• · The Charter Amendment was filed with the Delaware Secretary of State on July 23, 2026.
• · No fractional shares were issued; stockholders entitled to a fractional share received one whole share instead.
• · The common stock began trading on a split-adjusted basis on NYSE American under symbol APUS on July 24, 2026.
• · The new CUSIP number for the common stock is 03771D201.
• · Proportionate adjustments were made to outstanding equity awards and warrants and their exercise prices.
• · The company is an emerging growth company and has not elected to use the extended transition period for new accounting standards.

23-09-2026

HPS Corporate Lending Fund declared September 2026 distributions of $0.1990 per Class I share (net total) and reported an aggregate NAV of $12,264.6 million as of August 31, 2026. The fund's investment portfolio fair value was $23,174.3 million with $11,221.2 million in debt outstanding, resulting in an average debt-to-equity ratio of 0.92x. The fund has issued 568.4 million shares for total consideration of $14,273.9 million in its ongoing offering of up to $15.0 billion.

• · NAV per share for all classes was $24.45 as of August 31, 2026.
• · Average debt-to-equity ratio during August 2026 was approximately 0.92 times.
• · Distributions include a variable supplemental component of $0.0390 per share for all classes.
• · Record date for distributions is September 30, 2026; payment date is on or about October 30, 2026.
• · Class I shares have no shareholder servicing/distribution fee; Class S shares have the highest fee at $0.0171 per share.
• · Class I shares issued: 240,360,275 for $6,054.2 million; Class F shares issued: 240,078,280 for $6,005.7 million.

23-09-2026

HPS Corporate Capital Solutions Fund filed an 8-K on September 23, 2026, reporting the sale of 671,158 common shares for $18.31 million in an unregistered offering on September 1, 2026, at $27.29 per share. The fund also declared regular monthly distributions (Class I: $0.1390 net; Class D: $0.1334 net; Class S: $0.1199 net) and a special distribution of $0.125 per share, payable in late October 2026. As of August 31, 2026, the fund's aggregate NAV was $1,391.1 million, with a debt-to-equity ratio of 0.62x, and cumulative offering proceeds totaled $1,369.33 million from 52.4 million shares sold since August 2025.

• · The fund's average debt-to-equity ratio during August 2026 was approximately 0.62 times.
• · No Class S shares were sold in the September 1, 2026 subscription date.
• · Regular distributions for all share classes have a gross distribution of $0.1390 per share, with Class D and S incurring shareholder servicing/distribution fees of $0.0056 and $0.0191 respectively.
• · Special distribution of $0.125 per share is in addition to the regular monthly distribution.
• · The fund is an emerging growth company and has elected not to use the extended transition period for complying with new financial accounting standards.

23-09-2026

Northwest Natural Holding Co (NWN) announced a settlement in the Texas general rate case for its subsidiaries SiEnergy Gas, Pines Gas, and Pines Gas Development. The settlement provides for a revenue requirement increase of approximately $8.6 million, which is lower than the $12.0 million originally requested, and includes a 9.8% return on equity and an 8.0% overall cost of capital. New rates are expected to take effect in November 2026, subject to RRC approval.

• · The settlement consolidates SiEnergy Gas, Pines Gas, and Pines Gas Development into a single entity with systemwide rates.
• · The settlement includes baseline factors for future interim rate adjustments under Texas' GRIP program, which allows recovery of incremental capital between rate cases subject to prudence review.
• · SiEnergy must make an initial GRIP filing within two years of the rate case filing.
• · The settlement is subject to RRC review and approval; the RRC may approve, modify, or deny the terms.
• · New rates are expected to take effect in November 2026.

23-09-2026

Millrose Properties, Inc. priced a private offering of $1,000,000,000 in senior notes split into two tranches: $500,000,000 of 6.500% notes due 2029 and $500,000,000 of 6.750% notes due 2031, both at par. The offering is expected to close on October 6, 2026, and the proceeds will be used for general corporate purposes. The notes are being offered to qualified institutional buyers and non-U.S. persons under Rule 144A and Regulation S, and will not be registered under the Securities Act.

• · The notes are being offered at 100.000% of principal amount plus accrued interest from October 6, 2026.
• · The offering is exempt from registration under the Securities Act and is limited to qualified institutional buyers (Rule 144A) and non-U.S. persons (Regulation S).
• · The company has not disclosed the specific use of proceeds beyond general corporate purposes.

23-09-2026

News Corp filed a Form 8-K to disclose its daily buyback activity under its existing $1 billion stock repurchase program, as required by ASX rules. The filing includes copies of information provided to the ASX on the respective dates. The company reaffirmed its intent to repurchase shares from time to time but cautioned that actual results may vary due to market conditions and other risks.

• · The repurchase program covers both Class A (NWSA) and Class B (NWS) common stock.
• · Disclosure is made to comply with ASX rules for daily buyback reporting.
• · The filing includes forward-looking statements regarding the company's intent to repurchase shares.
• · The company disclaims any obligation to update forward-looking statements.
• · No specific repurchase amounts or shares bought back are disclosed in this 8-K.

23-09-2026

Tortoise Energy Infrastructure Corp (TYG) entered into a distribution agreement with PINE Distributors LLC on September 22, 2026, to sell up to 2,500,000 common shares through an at-the-market offering under its existing shelf registration. The company also engaged UBS Securities LLC as sub-placement agent. The offering is part of TYG's capital-raising activities, with no financial terms disclosed in the filing.

• · The offering is made under an effective shelf registration statement on Form N-2/ASR (File Nos. 333-295680; 811-21462) filed with the SEC on May 8, 2026.
• · The base prospectus is dated May 8, 2026, and the prospectus supplement is dated September 22, 2026.
• · The distribution agreement and sub-placement agent agreement are filed as Exhibits 1.1 and 1.2, respectively.
• · Venable LLP provided a legal opinion (Exhibit 5.1) regarding the issuance and sale of the common shares.

23-09-2026

CTT Pharmaceutical Holdings, Inc. (OTCQB:CTTH) announced the addition of Karen Larson as an Independent Board Member in an 8-K filing dated August 10, 2026. Mrs. Larson brings experience as a Certified Financial Planner (CFP), a former Senior Vice President and Investment Banker at Chase Manhattan Bank, and founder of a real estate company. The filing does not include any financial results, material agreements, or quantitative performance data.

• · Karen Larson is a Certified Financial Planner (CFP) and has experience running companies.
• · She created an analytical reporting business that was sold to Morningstar.
• · She served as Senior Vice President, Investment Banker at Chase Manhattan Bank.
• · Since 2017, she has spent 9 years as a founder of Broad Avenue Studios, Inc., a commercial and residential real estate company.
• · The filing date is August 10, 2026, but the report was signed on September 21, 2026.

23-09-2026

Algorhythm Holdings, Inc. (RIME) filed an 8-K on September 23, 2026, regarding the termination of a material agreement (Items 1.02, 7.01, 9.01). The filing includes Exhibit 99.1, but no specific financial figures, performance metrics, or period-over-period comparisons are provided in the available content. The event is classified as a material agreement termination, but without further details, the financial impact cannot be assessed.

• · Filing type: 8-K
• · Filing date: September 23, 2026
• · Items reported: 1.02 (Material Agreement Termination), 7.01 (Regulation FD Disclosure), 9.01 (Financial Statements and Exhibits)
• · Exhibit 99.1 is referenced but its content is not provided in the extracted text

23-09-2026

Zapata Quantum, Inc. announced early access to Quantum Pilot, a hardware-agnostic, cloud-based software platform designed to help enterprises systematically discover and develop high-value quantum applications. The platform combines a proprietary knowledge framework with computational tools, including capabilities from its collaboration with NVIDIA and the University of Maryland, to deliver Quantum Application Intelligence (QAI). The announcement is a product launch with no financial metrics disclosed, representing a strategic update rather than a financial event.

• · The platform is initially available through an early access program for select enterprise and government customers.
• · Zapata has a portfolio of more than 60 granted and pending patents developed over seven years.
• · The Company is the only organization to have participated across all technical areas of DARPA's Quantum Benchmarking program.
• · Zapata's study on quantum-enabled drug discovery was recognized as one of Nature Biotechnology's Top 10 Papers of 2025.
• · The press release contains forward-looking statements and risk factors, including reliance on the U.S. economy, tariffs, and ability to secure contracts.

23-09-2026

Ocugen, Inc. held a Special Meeting of Stockholders on September 21, 2026, at which stockholders approved an adjournment (Proposal 2) to allow more time to solicit additional proxies for Proposal 1, which would increase authorized common stock by 250,000,000 shares. The meeting was adjourned to October 5, 2026, solely on Proposal 1, as only 47.3% of outstanding shares were represented—exceeding the quorum but likely insufficient for the authorization increase. The adjournment proposal received strong support with 124,584,658 votes for, while 33,639,820 voted against.

• · Record date for voting was July 27, 2026.
• · The adjourned meeting will be held on October 5, 2026 at 8:00 a.m. ET virtually.
• · Stockholders who already voted on Proposal 1 need not take action unless they wish to change their vote.
• · Proposal 2 received 78.5% of votes cast in favor, indicating broad support for the delay.

23-09-2026

Terra Innovatum Global N.V. (NKLR) announced the resignation of three directors (Rex Jackson, Michael Howard, and Peter Hastings) effective September 17, 2026, and the appointment of three new independent directors (Tony Tullio, Michael Modro, and Kostadin Ivanov) effective September 22, 2026. Peter Hastings will transition to a consulting role supporting commercialization efforts. The new directors will enter into standard indemnification agreements. No financial figures or performance metrics were disclosed.

• · The resignations and appointments were effective on September 17 and September 22, 2026, respectively.
• · Peter Hastings will support the Company’s ongoing commercialization efforts and related strategic initiatives in a consulting role.
• · Tony Tullio was appointed interim chairman of the Board’s Audit Committee and as a member of the Board’s Remuneration Committee.
• · Each of the Resigning Directors and Independent Directors are expected to enter into an indemnification agreement with the Company.
• · The Company is an emerging growth company as defined under the Securities Act.